Monica Shalini Krishnan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiation Oncology | 6 | 2017 | 572 | 0.740 |
Why?
|
Palliative Care | 16 | 2023 | 3643 | 0.650 |
Why?
|
Life Expectancy | 3 | 2013 | 1248 | 0.600 |
Why?
|
Bone Neoplasms | 4 | 2018 | 2565 | 0.420 |
Why?
|
Pain | 4 | 2022 | 5100 | 0.330 |
Why?
|
Neoplasms | 12 | 2023 | 22371 | 0.330 |
Why?
|
Radiosurgery | 1 | 2018 | 1330 | 0.300 |
Why?
|
Lymph Node Excision | 1 | 2013 | 1271 | 0.270 |
Why?
|
Decision Making | 2 | 2021 | 3953 | 0.230 |
Why?
|
Models, Statistical | 2 | 2023 | 5107 | 0.180 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 4912 | 0.170 |
Why?
|
Karnofsky Performance Status | 1 | 2020 | 162 | 0.170 |
Why?
|
Clinical Clerkship | 2 | 2015 | 569 | 0.150 |
Why?
|
Goals | 1 | 2022 | 717 | 0.140 |
Why?
|
Internship and Residency | 1 | 2017 | 5953 | 0.130 |
Why?
|
Radiotherapy | 3 | 2018 | 1502 | 0.130 |
Why?
|
Lymphopenia | 1 | 2018 | 300 | 0.130 |
Why?
|
Cisplatin | 1 | 2021 | 1660 | 0.120 |
Why?
|
Critical Pathways | 1 | 2017 | 476 | 0.110 |
Why?
|
Lung Neoplasms | 3 | 2022 | 13586 | 0.090 |
Why?
|
Terminal Care | 2 | 2020 | 1770 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3583 | 0.090 |
Why?
|
Spinal Diseases | 1 | 2015 | 561 | 0.090 |
Why?
|
Axilla | 1 | 2013 | 623 | 0.090 |
Why?
|
Advance Care Planning | 1 | 2017 | 698 | 0.080 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 715 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2015 | 710 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2013 | 737 | 0.080 |
Why?
|
Prognosis | 6 | 2023 | 30010 | 0.070 |
Why?
|
Joint Instability | 1 | 2015 | 803 | 0.070 |
Why?
|
Career Choice | 1 | 2014 | 769 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2019 | 9118 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2507 | 0.070 |
Why?
|
Humans | 28 | 2023 | 768166 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3385 | 0.060 |
Why?
|
Qualitative Research | 3 | 2022 | 3140 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21206 | 0.060 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 3929 | 0.060 |
Why?
|
Students, Medical | 2 | 2015 | 1964 | 0.060 |
Why?
|
Nurses | 1 | 2013 | 2501 | 0.060 |
Why?
|
Curriculum | 2 | 2015 | 3782 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11244 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2013 | 2008 | 0.050 |
Why?
|
Female | 14 | 2021 | 397192 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3187 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2013 | 3474 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4755 | 0.050 |
Why?
|
Survival Analysis | 1 | 2013 | 10101 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15948 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2022 | 81762 | 0.040 |
Why?
|
Male | 13 | 2020 | 364719 | 0.040 |
Why?
|
Middle Aged | 11 | 2021 | 223492 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4282 | 0.040 |
Why?
|
Physicians | 2 | 2017 | 4598 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6283 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2021 | 899 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5706 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2017 | 2434 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5432 | 0.040 |
Why?
|
Cultural Characteristics | 1 | 2019 | 250 | 0.040 |
Why?
|
Death | 1 | 2022 | 683 | 0.040 |
Why?
|
Aged | 9 | 2021 | 171504 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8542 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2020 | 3620 | 0.030 |
Why?
|
Hospices | 1 | 2020 | 245 | 0.030 |
Why?
|
Morals | 1 | 2019 | 288 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2018 | 794 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2021 | 974 | 0.030 |
Why?
|
Dermatitis | 1 | 2017 | 203 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 54926 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2017 | 393 | 0.030 |
Why?
|
Spirituality | 1 | 2019 | 430 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 905 | 0.030 |
Why?
|
Chicago | 1 | 2014 | 255 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59629 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 2015 | 234 | 0.030 |
Why?
|
Mastectomy | 1 | 2021 | 1861 | 0.030 |
Why?
|
United States | 2 | 2017 | 73039 | 0.020 |
Why?
|
Patient Participation | 1 | 2021 | 1447 | 0.020 |
Why?
|
Back Pain | 1 | 2015 | 548 | 0.020 |
Why?
|
Boston | 2 | 2014 | 9374 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2015 | 65371 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1826 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13490 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20227 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1157 | 0.020 |
Why?
|
Hepatitis, Chronic | 1 | 1988 | 53 | 0.020 |
Why?
|
Microsomes, Liver | 1 | 1988 | 174 | 0.020 |
Why?
|
Microsomes | 1 | 1988 | 252 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2015 | 1273 | 0.020 |
Why?
|
Colitis | 1 | 2017 | 1242 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2916 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2923 | 0.020 |
Why?
|
Adult | 5 | 2021 | 223646 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 4057 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3269 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1300 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1969 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3905 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1988 | 423 | 0.020 |
Why?
|
Risk Factors | 1 | 2013 | 74944 | 0.020 |
Why?
|
Neutrophils | 1 | 2018 | 3786 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7852 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10632 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 1679 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8890 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2013 | 4310 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4858 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10840 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 60066 | 0.010 |
Why?
|
Kidney | 1 | 1988 | 7064 | 0.010 |
Why?
|
Immunoblotting | 1 | 1988 | 1647 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 2474 | 0.000 |
Why?
|
Blotting, Western | 1 | 1988 | 5027 | 0.000 |
Why?
|
Autoantibodies | 1 | 1988 | 2121 | 0.000 |
Why?
|
Child | 1 | 1988 | 80917 | 0.000 |
Why?
|